Global Cholesterol Testing Products and Services Market Size study, By Product (Testing Kits, Testing Strips, Others), By Test (Total Cholesterol Tests, High-Density Lipoprotein (HDL) Cholesterol Tests, Low-Density Lipoprotein (LDL) Cholesterol Tests, Tri

Global Cholesterol Testing Products and Services Market Size study, By Product (Testing Kits, Testing Strips, Others), By Test (Total Cholesterol Tests, High-Density Lipoprotein (HDL) Cholesterol Tests, Low-Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests, Others), By Age Group (Geriatric, Adult, Pediatric), By Application (Cardiovascular Diseases, Obesity, Diabetes, Hyperlipidemia, Others), By Service Provider (Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Care Centers, Others) and Regional Forecasts 2022-2032

The global cholesterol testing products and services market was valued at USD 19.70 billion in 2024 and is projected to grow at a robust compound annual growth rate (CAGR) of 8.4% during the forecast period 2024-2032.

This growth is attributed to an increasing emphasis on preventive healthcare, rising incidences of cardiovascular diseases (CVDs), and significant advancements in diagnostic technologies.

Cholesterol testing products and services play a vital role in detecting and managing hyperlipidemia and related diseases. Home-based testing kits and advanced point-of-care devices are transforming the diagnostic landscape by offering consumers greater accessibility and convenience. In addition, non-fasting cholesterol tests and multi-use testing strips enhance patient compliance, broadening the market appeal. Organizations like the CDC recommend routine cholesterol screenings every four to six years for adults at risk of coronary heart disease, underscoring the importance of early diagnosis.

Emerging economies in the Asia-Pacific region are experiencing the fastest growth due to rising health awareness, evolving dietary patterns, and increasing urbanization. Furthermore, regulatory support and government initiatives, coupled with investments in healthcare infrastructure, are accelerating the market expansion. The aging global population is also a key driver, with individuals aged 60 and above forming a growing demographic demanding frequent cholesterol monitoring. In contrast, North America dominated the market in 2024, leveraging its advanced healthcare infrastructure and extensive health awareness campaigns.

However, challenges such as the high costs of advanced cholesterol testing systems and limited awareness in certain regions could hinder market growth. Nonetheless, innovative solutions like affordable testing kits and enhanced public health initiatives create significant opportunities for market players.

The competitive landscape of the cholesterol testing market is shaped by strategic collaborations, technological advancements, and mergers and acquisitions aimed at expanding product portfolios and enhancing testing accuracy. Companies are increasingly focusing on R&D investments to introduce innovative testing solutions that meet the demands of diverse populations.

Major market players included in this report are:
• Quest Diagnostics Incorporated
• Eurofins Scientific
• Spectra Laboratories, Inc. (Fresenius Medical Care)
• Novartis AG
• Cell Biolabs, Inc.
• Randox Laboratories Ltd.
• SYNLAB AG
• BioReference Health, LLC
• Laboratory Corporation of America Holdings
• Thermo Fisher Scientific Inc.
• Clinical Reference Laboratory, Inc.
• Elabscience Bionovation Inc.
• Abbott Laboratories
• Roche Diagnostics
• Verichem Laboratories

The detailed segments and sub-segments of the market are explained below:

By Product
• Testing Kits
• Testing Strips
• Others

By Test
• Total Cholesterol Tests
• High-Density Lipoprotein (HDL) Cholesterol Tests
• Low-Density Lipoprotein (LDL) Cholesterol Tests
• Triglyceride Tests
• Others

By Age Group
• Geriatric
• Adult
• Pediatric

By Application
• Cardiovascular Diseases
• Obesity
• Diabetes
• Hyperlipidemia
• Others

By Service Provider
• Hospitals and Clinics
• Diagnostic Laboratories
• Ambulatory Care Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Rest of Asia Pacific
• Latin America
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand-side and supply-side analysis of the market.